Gene · 6335
Papers3,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring GC-MS-Based Phytochemistry and Network Pharmacology to Elucidate the Multi-Target Therapeutic Potential of Betel Leaf Oil as an Analgesic and Anti-Inflammatory Agent. | Biomed Chromatogr | 2026 | 42530450 | PubTator, text mining | PubMed |
| Repurposing FDA-Approved Drugs as Nav1.7 Channel Modulators: An Integrated Structure-Based Virtual Screening and Molecular Dynamics Study. | Int J Mol Sci | 2026 | 42511819 | PubTator, text mining | PubMed |
| Electrostatic tuning of NaV channel activation by the domain II S3-S4 extracellular loop. | J Physiol | 2026 | 42499265 | PubTator, text mining | PubMed |
| Association of the SCN9A rs6746030 (R1150W) Polymorphism on Inferior Alveolar Nerve Block Failure in Symptomatic Irreversible Pulpitis. | Int Endod J | 2026 | 42495805 | PubTator, text mining | PubMed |
| Boy in the Barrel: Excruciating Paroxysmal Pain Disorder Associated With an SCN9A Gain-of-Function Variant. | J Peripher Nerv Syst | 2026 | 42437972 | PubTator, text mining | PubMed |
| Co-Occurrence of SCN9A and PRRT2 Variants in a Patient With Paroxysmal Extreme Pain Disorder, Contradictory Analgesia, and Intractable Paroxysmal Non-Kinesigenic Dyskinesia. | Case Rep Med | 2026 | 42344103 | PubTator, text mining | PubMed |
| Rapid generation of human sensory neurons from iPSC for modeling of peripheral neuropathies. | J Neurosci Methods | 2026 | 42336247 | PubTator, text mining | PubMed |
| Isoform-Specific NaV Modulation in Painful Chemotherapy-Induced Neuropathy: Promise, Limitations, and a Clinical Agenda. | CNS Drugs | 2026 | 42334794 | PubTator, text mining | PubMed |
| Association between voltage-gated sodium channel gene polymorphisms and chronic oxaliplatin-induced peripheral neuropathy in Japanese patients with colorectal cancer. | J Pharm Health Care Sci | 2026 | 42321904 | PubTator, text mining | PubMed |
| Integrating machine learning and retrospective cohort to explore the effects of AEDs on the prognosis of LGG and identify related molecular targets. | BMC Pharmacol Toxicol | 2026 | 42298735 | PubTator, text mining | PubMed |
| The elusive management of an individual patient with SCN9A sodium channelopathy in the perioperative setting. | Pain | 2026 | 42294779 | PubTator, text mining | PubMed |
| Successful Novel Treatment of Primary Erythromelalgia with Popliteal Sciatic Nerve Block and Peripheral Nerve Stimulation: A Case Report. | Pain Med Case Rep | 2026 | 42263285 | PubTator, text mining | PubMed |
| Microfluidics-Enabled Nanoparticle for Multiscale Synergetic Osteoarthritis Therapy. | ACS Nano | 2026 | 42261255 | PubTator, text mining | PubMed |
| A landscape analysis of clinical trials in cancer pain management: current trends and emerging therapeutic targets. | Front Oncol | 2026 | 42239899 | PubTator, text mining | PubMed |
| Alternative splicing of Scn9a exon 5: mechanistic insights and therapeutic potential in pain disorders. | Hum Mol Genet | 2026 | 42224458 | PubTator, text mining | PubMed |
| Trigeminal neuralgia: from clinical challenges to molecular insights. | J Headache Pain | 2026 | 42210053 | PubTator, text mining | PubMed |
| [Congenital insensitivity to pain caused by a novel SCN9A-genotype]. | Laeknabladid | 2026 | 42201790 | PubTator, text mining | PubMed |
| Distribution of divalent small interfering RNA into neurons of sensory ganglia produces selective, durable knockdown of Nav1.7 and strong analgesia. | Pain | 2026 | 42187058 | PubTator, text mining | PubMed |
| Identification of the SCN9A Variant c.647T>C (p. Phe216Ser) in a Patient With Primary Erythromelalgia. | J Dermatol | 2026 | 42186157 | PubTator, text mining | PubMed |
| NaV1.7 mRNA and Protein Expression in Resident Neurons of the Human Spinal Dorsal Horn. | J Comp Neurol | 2026 | 42138993 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6335/papers?page=2